|Nombre||Título||Paga||Ejecutado||Año de nacimiento|
|Mr. Ronan Levy||Co-Founder & Exec. Chairman||N/A||N/A||1980|
|Mr. Joseph del Moral||Co-Founder, CEO & Director||N/A||N/A||1979|
|Mr. Hannan Fleiman||CO-Founder, Pres & Director||N/A||N/A||1981|
|Mr. Mujeeb Jafferi||CO-Founder & COO||N/A||N/A||1984|
|Dr. Ryan D. Yermus||Co-Founder & Chief Clinical Officer||N/A||N/A||1982|
|Ms. Donna K. Wong||Chief Financial Officer||N/A||N/A||1967|
|Mr. Matt Emmer||Director of Operations & Bus. Devel.||N/A||N/A||N/A|
|Mr. Amardeep Manhas||Chief Technology Officer||N/A||N/A||1984|
|Dr. Nathan Bryson B.Sc., Ph.D.||Chief Scientific Officer||N/A||N/A||1964|
|Ms. Paula Amy Hewitt||VP, Gen. Counsel & Corp. Sec.||N/A||N/A||1973|
Field Trip Health Ltd. engages in the development and delivery of psychedelic therapies in North America. The company operates Field Trip Health Centres that provide psychedelic therapies; offers Field Trip Digital apps; and Field Trip Discovery, a drug development division developing the next generation of psychedelic molecules. Field Trip Health Ltd. was founded in 2008 and is headquartered in Toronto, Canada.
El ISS Governance QualityScore de Field Trip Health Ltd., a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.